High levels of gut bacterial toxin trigger lupus nephritis
Research suggests that using antibiotics to target the Ruminococcus gnavus lipoglycan, or the protein it activates on immune cell surfaces to amplify damaging inflammation, could serve as an alternative to current lupus nephritis therapies that suppress the immune system.
Registered users, subscribers or members - SIGN IN
To continue reading this article
Membership
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
Find out more about how to join.
Register
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
Subscribe
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.